22nd Century Group (OTC: XXII) Files FDA Renewal for VLN® MRTP Status
Market Overview 22nd Century Group, Inc. (OTC: XXII) continues to navigate the complex regulatory environment surrounding tobacco products as it works to maintain its position in the market. The company’s stock has drawn attention from investors interested in tobacco alternatives and regulatory developments impacting the industry. Market sentiment reflects cautious optimism as 22nd Century Group pushes forward in its quest for longer-term modified risk marketing authorization. In recent months, 22nd…
